Skip to main content
. 2017 Feb;29(1):86–92. doi: 10.21147/j.issn.1000-9604.2017.01.10

2.

Comparison of mean and median survival of CRS+ HIPEC+EPIC versus chemotherapy groups (Ref 16)

Treatment Case No. Survival (month)
Mean Median
CRS, cytoreductive surgery; HIPEC, hyperthermic intraperitoneal chemotherapy; EPIC, early postoperative intraperitoneal chemotherapy. P values were not provided.
Chemotherapy 10 11.1 10.4
CRS+HIPEC+EPIC 7 20.5 15.3